BBusiness Read More Moderna (MRNA) Q2 2025 earningsAugust 1, 2025 Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images…
BBusiness Read More Moderna to slash 10% of workforce amid Covid vaccine salesJuly 31, 2025 The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images…
BBusiness Read More Vinay Prasad departs FDA | STATJuly 30, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
BBusiness Read More UnitedHealth Group (UNH) earnings report Q2 2025July 29, 2025 UnitedHealth Group on Tuesday issued a 2025 outlook that fell short of Wall Street’s expectations, as the company’s…
BBusiness Read More FDA clears way for Sarepta Therapeutics to use Duchenne drug in some patientsJuly 29, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
AArtificial intelligence Read More Mayo Clinic Deploys NVIDIA Blackwell Infrastructure to Drive Generative AI Solutions in MedicineJuly 28, 2025 Newswise — ROCHESTER, Minn. — Mayo Clinic took a pivotal step toward integrating AI solutions in the clinical setting with…
MMedication Read More Shortage of pain meds like Percocet sparks concern in CanadaJuly 26, 2025 This news must have been a hard pill to swallow. There is a nationwide shortage of common prescription…
BBusiness Read More As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middleJuly 25, 2025 Jennifer Hill Blair recognized the Cincinnati number on her buzzing phone and slipped out of the school meeting,…
BBusiness Read More UnitedHealth facing DOJ investigation over Medicare billingJuly 24, 2025 UnitedHealth Group revealed Thursday it is facing a Department of Justice investigation over its Medicare billing practices, adding…
BBusiness Read More Sarepta Therapeutics’ Elevidys faces ‘arduous’ path back to marketJuly 22, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
BBusiness Read More Sarepta will stop shipping Elevidys, Duchenne gene therapyJuly 22, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
AArtificial intelligence Read More AI turns old diabetes drug Halicin into a potent weapon against superbugsJuly 21, 2025 Can an AI-repurposed diabetes drug tackle our toughest superbugs? Researchers reveal Halicin’s powerful action against deadly multidrug-resistant bacteria,…